このアイテムのアクセス数: 374

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
29_1567.pdf475.54 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author大越, 正秋ja
dc.contributor.alternativeOhkoshi, Masaakien
dc.date.accessioned2010-06-03T04:36:58Z-
dc.date.available2010-06-03T04:36:58Z-
dc.date.issued1983-12-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/120315-
dc.description.abstractIntraoperative wound infection and postoperative pulmonary and urinary tract infections are the major problems that face the transplant surgeon today. These infections are the major cause of the mortality after renal transplantation. Almost any microorganism could be causative. But, in this paper, only bacterial infections will be discussed. Prophylaxis of intraoperative infection is the same as that used for general surgery. In addition, one of the major defects in the recipient is defective renal function, resulting in general weakness. The use of broad-spectrum antibacterial agents (eg, cefmetazole etc.), effective against many different bacteria from gram-positive cocci to gram negative rods, administered to these patients will produce dramatic results. Aminoglycosides are nephrotoxic and should not be given to the patients having renal failure. Piperacillin or the third generational cephems (ceftizoxime, latamoxef , cefotaxime, cefmenoxime, ceftriaxon and ceftazidime) are the drugs of choice for postoperative infections, especially for urinary tract infections. Pseudomonas aeruginosa should be treated with cefsulodin, cefoperazone, or cefpiramide by the intravenous route. After chemotherapeutic and antibiotic therapy sterilizes the urine, this should be followed by suppressive therapy with quinolone- carboxylic acid (pipemidic acid, norfloxacin, enoxacin and DL-8280), combinations of sulfamethoxazole and trimethoprim, sulfonamides, or fosfomycin for many weeks or months. In chronic antimicrobial suppression treatment, half-doses should be given at bedtime.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectAminoglycosides/therapeutic useen
dc.subjectAnti-Bacterial Agents/therapeutic useen
dc.subjectAnti-Infective Agents, Urinary/therapeutic useen
dc.subjectBacterial Infections/drug therapy/prevention & controlen
dc.subjectCephalosporins/therapeutic useen
dc.subjectHumansen
dc.subjectIntraoperative Complications/drug therapy/prevention & controlen
dc.subjectKidney Transplantationen
dc.subjectPenicillins/therapeutic useen
dc.subjectPostoperative Complications/drug therapy/prevention & controlen
dc.subjectPremedicationen
dc.subjectQuinolines/therapeutic useen
dc.subject.ndc494.9-
dc.title腎移植における細菌感染症の化学療法 付 : 最近の抗菌薬ja
dc.title.alternativeChemotherapy for bacterial infections in renal transplantation and recent antibacterial agentsen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume29-
dc.identifier.issue12-
dc.identifier.spage1567-
dc.identifier.epage1577-
dc.textversionpublisher-
dc.sortkey01-
dc.address東海大学医学部泌尿器科学教室ja
dc.address.alternativeThe Department of Urology, Tokai University, School of Medicineen
dc.identifier.pmid6375310-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.29 No.12

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。